Truist analyst Tobey Sommer raised the firm’s price target on Huron to $100 from $85 and keeps a Buy rating on the shares after its Q4 earnings beat and guidance. The company’s outlook for 10% revenue growth in 2023 could again prove conservative as revenue guidance could be achieved with modest headcount growth from Q4 level, the analyst tells investors in a research note. Huron is well positioned to benefit from financial distress at Hospitals and Universities as well as expansion of the rapidly-growing Digital platform, Truist added.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HURN: